45 results on '"LEONARD, JAMES B."'
Search Results
2. Case Study: Treating Infants for Cannabis Exposure: As more and more states legalize recreational marijuana, caregivers need to be vigilant about keeping products out of the reach of children
3. Fomepizole use reported to United States Poison Centers from 2010 to 2021.
4. The Ones the Law Forgot: Children Working in Agriculture.
5. Treating an 18-month-old who tested positive for cannabis exposure
6. A descriptive study of aripiprazole, brexpiprazole, and cariprazine exposures in children ages 0 to 5 years reported to United States poison centers
7. Adolescent Occupational Exposures Reported to United States Poison Centers, 2011–2020
8. Changes in unintentional cannabis exposures in children 6 months to 5 years reported to United States poison centers during the first nine months of the coronavirus-19 pandemic
9. Critical care interventions in children aged 6 months to 12 years admitted to the pediatric intensive care unit after unintentional cannabis exposures
10. Evaluation of level of care for toxic alcohol ingestions receiving fomepizole
11. In vitro analysis of n-acetylcysteine (NAC) interference with the international normalized ratio (INR)
12. Exposures in pregnant patients reported to United States Poison Centers
13. Clinical effects and outcomes of perampanel overdoses reported to U.S. poison centers
14. Flecainide Toxicity Secondary to Accidental Overdose: A Pediatric Case Report of Two Brothers
15. Time to peak INR rise in acute and acute on chronic warfarin overdoses
16. In vitro analysis of n-acetylcysteine (NAC) interference with the international normalized ratio (INR).
17. Safety and efficacy of pharmacologic agents used for rapid tranquilization of emergency department patients with acute agitation or excited delirium
18. Exposures in pregnant patients reported to United States Poison Centers.
19. Clinical effects and outcomes of perampanel overdoses reported to U.S. poison centers.
20. Impact of a drug safety communication on the severity of benzonatate exposures reported to poison centers
21. An analysis of fatal iatrogenic therapeutic errors reported to United States poison centers
22. Iron Packaging Regulations in the United States and Pediatric Morbidity: A Retrospective Cohort Study
23. Toxicity of acute exploratory amphetamine-salt medication in amphetamine-naïve pediatrics: a retrospective cohort study
24. Outcomes of acute exploratory pediatric lithium ingestions
25. Challenges with uptake of critical health messages to healthcare providers during an outbreak of a novel health condition
26. Steel yourself! Trends in iron packaging regulations in the United States and pediatric morbidity
27. Background & Objective Conclusion Case Report Use of veno-arterial extracorporeal membrane oxygenation in life-threatening bupropion ingestion in a pediatric patient
28. Time to Peak International Normalized Ratio Rise in Acute and Acute-on-Chronic Warfarin Overdoses.
29. Overtime law and white-collar workers.
30. Prepacked naloxone administration for suspected opioid overdose in the era of illicitly manufactured fentanyl: a retrospective study of regional poison center data
31. Prime eligible poisons: identification of extremely hazardous substances available on Amazon.com®
32. Characterization of intentional-abuse venlafaxine exposures reported to poison control centers in the United States
33. Using a spare medication vial to store multiple medications: A potentially fatal in-home medication error
34. The others: characterizing “other” therapeutic errors reported to a poison center
35. An analysis of fatal iatrogenic therapeutic errors reported to United States poison centers.
36. Impact of a drug safety communication on the severity of benzonatate exposures reported to poison centers.
37. Prepacked naloxone administration for suspected opioid overdose in the era of illicitly manufactured fentanyl: a retrospective study of regional poison center data.
38. Prime eligible poisons: identification of extremely hazardous substances available on Amazon.com®.
39. Prime eligible poisons: identification of extremely hazardous substances available on Amazon.com®.
40. Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016
41. Metoclopramide induced pheochromocytoma crisis
42. Potential drug interaction with opioid agonist in the setting of chronic low-dose opioid antagonist use
43. Federal overtime law
44. Don't weaken labor law's 'hot goods' provision
45. Prime eligible poisons: identification of extremely hazardous substances available on Amazon.com ® .
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.